These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A condensate-hardening drug blocks RSV replication in vivo. Risso-Ballester J; Galloux M; Cao J; Le Goffic R; Hontonnou F; Jobart-Malfait A; Desquesnes A; Sake SM; Haid S; Du M; Zhang X; Zhang H; Wang Z; Rincheval V; Zhang Y; Pietschmann T; Eléouët JF; Rameix-Welti MA; Altmeyer R Nature; 2021 Jul; 595(7868):596-599. PubMed ID: 34234347 [TBL] [Abstract][Full Text] [Related]
4. Experimental Considerations for the Evaluation of Viral Biomolecular Condensates. Roden CA; Gladfelter AS Annu Rev Virol; 2024 Sep; 11(1):105-124. PubMed ID: 39326881 [TBL] [Abstract][Full Text] [Related]
5. The future of antivirals: broad-spectrum inhibitors. Debing Y; Neyts J; Delang L Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332 [TBL] [Abstract][Full Text] [Related]
6. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products. Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182 [TBL] [Abstract][Full Text] [Related]
7. Intervention strategies for emerging viruses: use of antivirals. Debing Y; Jochmans D; Neyts J Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity Exerted by Natural Products against Human Viruses. Musarra-Pizzo M; Pennisi R; Ben-Amor I; Mandalari G; Sciortino MT Viruses; 2021 May; 13(5):. PubMed ID: 34064347 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of virus replication: recent developments and prospects. Magden J; Kääriäinen L; Ahola T Appl Microbiol Biotechnol; 2005 Mar; 66(6):612-21. PubMed ID: 15592828 [TBL] [Abstract][Full Text] [Related]
12. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Zheng Y; Li S; Song K; Ye J; Li W; Zhong Y; Feng Z; Liang S; Cai Z; Xu K Viruses; 2022 Apr; 14(5):. PubMed ID: 35632670 [TBL] [Abstract][Full Text] [Related]
13. Rapid Reversible Osmoregulation of Cytoplasmic Biomolecular Condensates of Human Interferon-α-Induced Antiviral MxA GTPase. Sehgal PB; Yuan H; Jin Y Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361529 [TBL] [Abstract][Full Text] [Related]
14. HSP90: a promising broad-spectrum antiviral drug target. Wang Y; Jin F; Wang R; Li F; Wu Y; Kitazato K; Wang Y Arch Virol; 2017 Nov; 162(11):3269-3282. PubMed ID: 28780632 [TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum antivirals against viral fusion. Vigant F; Santos NC; Lee B Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364 [TBL] [Abstract][Full Text] [Related]
17. Broad-Spectrum Antivirals and Antiviral Drug Combinations. Oksenych V; Kainov DE Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894 [TBL] [Abstract][Full Text] [Related]
18. Seeing Biomolecular Condensates Through the Lens of Viruses. Borodavka A; Acker J Annu Rev Virol; 2023 Sep; 10(1):163-182. PubMed ID: 37040799 [TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing for Viral Infectious Diseases: How Far Are We? Mercorelli B; Palù G; Loregian A Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926 [TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses. He Y; Zhou J; Gao H; Liu C; Zhan P; Liu X Eur J Med Chem; 2024 Feb; 265():116069. PubMed ID: 38160620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]